Biocon Pays $3.3bn For Viatris Biosimilars Business

‘Transformational’ Deal Offers Biocon Portfolio, Pipeline And Global Presence

 
• By David Wallace
  
Jigsaw pieces sunset
The deal combines Biocon Biologics with Viatris biosimilars • Source: rangizzz / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business